Melnick A - Search Results

1

Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies.

Oyer JA, Huang X, Zheng Y, Shim J, Ezponda T, Carpenter Z, Allegretta M, Okot-Kotber CI, Patel JP, Melnick A, Levine RL, Ferrando A, Mackerell AD Jr, Kelleher NL, Licht JD, Popovic R. Oyer JA, et al. Among authors: melnick a. Leukemia. 2014 Jan;28(1):198-201. doi: 10.1038/leu.2013.204. Epub 2013 Jul 4. Leukemia. 2014. PMID: 23823660 Free PMC article. No abstract available.

2

Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia.

Licht JD, Shaknovich R, English MA, Melnick A, Li JY, Reddy JC, Dong S, Chen SJ, Zelent A, Waxman S. Licht JD, et al. Among authors: melnick a. Oncogene. 1996 Jan 18;12(2):323-36. Oncogene. 1996. PMID: 8570209

3

Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Melnick A, Licht JD. Melnick A, et al. Blood. 1999 May 15;93(10):3167-215. Blood. 1999. PMID: 10233871 Free article. Review. No abstract available.

4

The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase.

Ball HJ, Melnick A, Shaknovich R, Kohanski RA, Licht JD. Ball HJ, et al. Among authors: melnick a. Nucleic Acids Res. 1999 Oct 15;27(20):4106-13. doi: 10.1093/nar/27.20.4106. Nucleic Acids Res. 1999. PMID: 10497277 Free PMC article.

5

Identification of novel chromosomal rearrangements in acute myelogenous leukemia involving loci on chromosome 2p23, 15q22 and 17q21.

Melnick A, Fruchtman S, Zelent A, Liu M, Huang Q, Boczkowska B, Calasanz M, Fernandez A, Licht JD, Najfeld V. Melnick A, et al. Leukemia. 1999 Oct;13(10):1534-8. doi: 10.1038/sj.leu.2401513. Leukemia. 1999. PMID: 10516754

6

A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF.

Hoatlin ME, Zhi Y, Ball H, Silvey K, Melnick A, Stone S, Arai S, Hawe N, Owen G, Zelent A, Licht JD. Hoatlin ME, et al. Among authors: melnick a. Blood. 1999 Dec 1;94(11):3737-47. Blood. 1999. PMID: 10572087 Free article.

7

The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.

Melnick AM, Westendorf JJ, Polinger A, Carlile GW, Arai S, Ball HJ, Lutterbach B, Hiebert SW, Licht JD. Melnick AM, et al. Mol Cell Biol. 2000 Mar;20(6):2075-86. doi: 10.1128/MCB.20.6.2075-2086.2000. Mol Cell Biol. 2000. PMID: 10688654 Free PMC article.

8

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Melnick A, Ahmad KF, Arai S, Polinger A, Ball H, Borden KL, Carlile GW, Prive GG, Licht JD. Melnick A, et al. Mol Cell Biol. 2000 Sep;20(17):6550-67. doi: 10.1128/MCB.20.17.6550-6567.2000. Mol Cell Biol. 2000. PMID: 10938130 Free PMC article.

9

AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.

Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD. Melnick A, et al. Blood. 2000 Dec 1;96(12):3939-47. Blood. 2000. PMID: 11090081 Free article.

10

Translocations of the RARalpha gene in acute promyelocytic leukemia.

Zelent A, Guidez F, Melnick A, Waxman S, Licht JD. Zelent A, et al. Among authors: melnick a. Oncogene. 2001 Oct 29;20(49):7186-203. doi: 10.1038/sj.onc.1204766. Oncogene. 2001. PMID: 11704847 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

464 results

Search Page

Filters